Skip to content

The TREFOIL Concept 5 Year Clinical Investigation

The TREFOIL Concept: A Clinical Investigation in the Mandible on 3 Implants With a Fixed Prefabricated Framework

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02940353
Enrollment
110
Registered
2016-10-20
Start date
2016-04-30
Completion date
2022-06-30
Last updated
2023-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Edentulous or Failing Dentition Mandible

Brief summary

Prospective, single cohort, multi-center study evaluating the TREFOIL concept for the treatment of edentulous or patients with failing mandibular dentition over 5 years. 90 patients (15 per centre) will be included. The subject population is at least 18 years old, in need of an implant restored full prosthesis providing sufficient bone in the interforaminal where a fixed restoration on three implants is regarded as an appropriate treatment solution. The components are TREFOIL treatment concept (implants and framework).

Interventions

DEVICETREFOIL concept

Sponsors

Nobel Biocare
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Obtained informed consent from the subject. * The subject is at least 18 years of age (passed cessation of growth) and not older than 80 years. * The subject is in such a physical and mental condition that a 5-year follow-up period can be carried out without foreseeable problems. * The subject fulfills the prerequisite that a harmonic, stable occlusal relationship can be achieved with opposing natural teeth resp. fixed or removable opposing dentition (tooth or implant based) or soft tissue born denture. * The subject is willing and able to comply with all study related procedures (such as exercising oral hygiene and attending all follow-up procedures). * The subject is compliant with good oral hygiene. * The subject has an edentulous mandible or failing mandibular dentition providing sufficient bone in the interforaminal where a fixed restoration on three (3) implants is regarded as an appropriate treatment solution. * The subject has an osseous architecture enough to receive three implants with a length of at least 11.5 mm and a diameter of 5 mm in the interforaminal (e.g. jaw volume B, C or D; inter foramina distance at least 20 mm; buccal/lingual width at least 6-7 mm, vertical height after leveling bone sufficient to receive an implant of at least 11.5 mm length). * The subject has a jaw curvature that fits to the prefabricated framework design. * Implants will be placed in healed or extraction sites (clinical stability has to be ensured). * The implant sites are free from infection and extraction remnants. * The subjects as well as the implant sites fulfill the criteria for early loading. Smokers that have reduced their consumption may be included after a certain test phase (e.g. test phase for reduction from 2 to 1 packages of cigarettes should be at least 6 months). Class II inter-jaw relation patients are not an

Exclusion criteria

per se. Based on the individual judgment of the clinician those patients may be treated. Subject inclusion criteria at time of surgery * After bone leveling sufficient mandible bone volume in the interforaminal present for three (3) implants with a length of at least 11.5 mm and a diameter of 5 mm. * After bone leveling the jaw curvature does fit to the prefabricated framework. * The implant sites are free from infection and extraction remnants. * The subject as well as the implant sites fulfill the criteria for early loading.

Design outcomes

Primary

MeasureTime frame
Cumulative survival rates for the implants5 years

Countries

Australia, Chile, Italy, Spain, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026